COYA – coya therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Coya Therapeutics CEO Dr. Arun Swaminathan Issues Letter to Stockholders
Coya Therapeutics, Inc. (NASDAQ: COYA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $18.00 price target on the stock.
Coya Therapeutics, Inc. (NASDAQ: COYA) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $14.00 price target on the stock.
Coya Therapeutics Provides a Corporate Update and Reports Unaudited Third Quarter 2024 Financial Results
Coya Therapeutics Announces Arun Swaminathan, Ph.D. Assumes New Role as Chief Executive Officer [Yahoo! Finance]
Form S-3 Coya Therapeutics, Inc.
Form 4 Coya Therapeutics, Inc. For: Nov 14 Filed by: SNYDER DAVID S
Form 4 Coya Therapeutics, Inc. For: Nov 13 Filed by: Swaminathan Arun
Form 4 Coya Therapeutics, Inc. For: Nov 11 Filed by: Grossman Fred
Form 4 Coya Therapeutics, Inc. For: Nov 11 Filed by: Swaminathan Arun
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.